MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Xencor Announces Promising Early Results for XmAb942 in First-in-Human Study Targeting IBD

CollPlant Biotechnologies Reports Second Quarter 2025 Financial Results and Provides Corporate Update

20 Aug 2025

CollPlant Biotechnologies a regenerative and aesthetics medicine company developing innovative...

Niagen Bioscience's Pharmaceutical-Grade Niagen™ IV and Injections Are Now Available at Over 50 iCRYO Clinics and More Than 900 Clinics Nationwide

Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive Alzheimer’s Biomarker Detection

$CellCentric Launches DOMMINO-1, a Phase 2 Trial of Inobrodib Combined with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma$

CellCentric Launches DOMMINO-1, a Phase 2 Trial of Inobrodib Combined with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

Nnamdi Njoku Named President of Omnicell

By Omnicell, Inc.
Omnicell, Inc.
01 Jul 2026

Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

By Novo Nordisk
Novo Nordisk
01 Jul 2026

Queue Secures $12.6 Million to Launch the World's First Fully Autonomous Robotic Pharmacy

By Queue
Queue
30 Jun 2026

Avenacy Launched Norepinephrine Bitartrate Injection, USP in the U.S. Market

By Avenacy
Avenacy
29 Jun 2026

Johnson & Johnson Strengthens European Cardiac Care with the Introduction of the Dual Energy THERMOCOOL SMARTTOUCH SF Ablation Platform

By Johnson & Johnson
Johnson & Johnson
25 Jun 2026

StatLab Introduces CytoPath Disc, Enhancing Global Standards in Cell Block Preparation

By StatLab Medical Products
StatLab Medical Products
25 Jun 2026

The Digital Pharma Advances Conference 2026

Most Popular

Galvanize Therapeutics receives FDA clearance for the Aliya EX Generator, expanding its Aliya Pulsed Electric Field portfolio

By Galvanize Therapeutics, Inc.

May 18
HanAll Biopharma releases Q3 2024 financial results and shares business updates

By HanAll Biopharma

Nov 01
Bavarian Nordic gets a HERA order and announces a major vaccine donation for the Mpox outbreak in Africa

By Bavarian Nordic A/S

Aug 13

July 2026

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Xencor Announces Promising Early Results for XmAb942 in First-in-Human Study Targeting IBD

CollPlant Biotechnologies Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Niagen Bioscience's Pharmaceutical-Grade Niagen™ IV and Injections Are Now Available at Over 50 iCRYO Clinics and More Than 900 Clinics Nationwide

Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive Alzheimer’s Biomarker Detection

CellCentric Launches DOMMINO-1, a Phase 2 Trial of Inobrodib Combined with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

Nnamdi Njoku Named President of Omnicell

Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

Queue Secures $12.6 Million to Launch the World's First Fully Autonomous Robotic Pharmacy

Avenacy Launched Norepinephrine Bitartrate Injection, USP in the U.S. Market

Johnson & Johnson Strengthens European Cardiac Care with the Introduction of the Dual Energy THERMOCOOL SMARTTOUCH SF Ablation Platform

StatLab Introduces CytoPath Disc, Enhancing Global Standards in Cell Block Preparation

Most Popular

Galvanize Therapeutics receives FDA clearance for the Aliya EX Generator, expanding its Aliya Pulsed Electric Field portfolio

HanAll Biopharma releases Q3 2024 financial results and shares business updates

Bavarian Nordic gets a HERA order and announces a major vaccine donation for the Mpox outbreak in Africa

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe to Our Monthly Newsletter